Summary
Uptake of catechol isoquinolines to dopamine cells was studied using human dopaminergic neuroblastoma SH-SY5Y cells. Only (R)-1,2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline [(R)-1,2-DiMeDHTIQ] was transported by dopamine uptake system, while (S)-1,2-DiMeDHTIQ, (R)- and (S)-1-methyl-6,7-dihydroxy-tetrahydroisoquinoline, and 1,2-dimethyl-6,7-dihydroxyisoquinolinum ion were not. Kinetical study showed that the uptake of (R)-1,2-DiMeDHTIQ followed the Michaelis-Menten equation, and the values of the Michaelis constant and the maximal velocity were obtained to be 102.6 ± 36.9 μM and 66.0 ± 2.8 pmol/min/mg protein. Dopamine was found to inhibit (R-1-DiMeDHTIQ uptake competitively. These results suggest that the selective uptake by dopamine transporter may account for the specific neurotoxicity of (R)-1,2-DiMeDHTIQ to dopamine neurons.
Similar content being viewed by others
Abbreviations
- MAO :
-
monoamine oxidase
- MPTP :
-
1-methyl-4-phenyl-1,2,3,6-tetrahy-dropyridine
- MPP + :
-
1-methyl-4-phenylpyridinium ion
- 1-MeDHTIQ :
-
1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
- 1,2-DiMeDHTIQ :
-
1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
- 1,2-DiMeDHIQ + :
-
1,2-dimethyl-6,7-dihydroxyisoquinolinium ion
- 2-MeDHIQ + :
-
2-methyl-6,7-dihydroxyisoquinolinium ion
- TIO :
-
1,2,3,4-tetrahydroisoquinoline
References
Bembenek ME, Abell CW, Chrisey LA, Rozwadwska MD, Gessner W, Brossi A (1990) Inhibition of monoamine oxidase A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines. J Med Chem 33: 147–152
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal Biochem 72: 248–254
Chiba K, Trevor A, Castagnoli Jr N (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120: 574–578
Dostert P, Strolin Benedetti M, Dordain G (1988) Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's disease. J Neural Transm 74: 61–74
Dostert P, Strolin Benedetti M, Bellotti V, Allievi C, Dordain G (1990) Biosynthesis of salsolinol, a tetrahydroisoquinoline alkaloid, in healthy subjects, J Neural Transm 81: 215–223
Javitch JA, D'Amato RJ, Strittmatter SM, Synder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82: 2173–2177
Langston JW, Irwin I, Langston EB, Forno LS (1984) Pargyline prevents MPTP-induced Parkinsonism in primates. Science 225: 1480–1482
Maruyama W, Nakahara D, Ota M, Takahashi T, Takahashi A, Nagatsu T, Naoi M (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)salsolinol, in rat brain: in vivo microdialysis study. J Neurochem 59: 395–400
Maruyama W, Nakahara D, Dostert P, Hashiguchi H, Ohta S, Hirobe M, Takahashi A, Nagatsu T, Naoi M (1993) Selective release of serotonin by endogenous alkaloid, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R) and (S) salsolinol, in rat brain: in vivo microdialysis study. Neurosci Lett 149: 115–118
Matsubara K, Collins MA, Kobayashi S, Akane A, Ikebuchi J, Takahashi S, Neafsey EJ, Kimura K (1994) Presence of N-methylated β-carbolinium ions, potential neurotoxic analogs of MPP+, in human brain and cerebrospinal fluid. In: Hanin I, Yoshida M, Fisher A (eds) Alzheimer's and Parkinson's diseases: recent development. Plenum Press, New York London (in press)
Nagatsu T, Yoshida M (1988) An endogenous substrate of brain, tetrahydro isoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87: 178–182
Naoi M, Matsuura S, Parvez H, Takahashi T, Hirata Y, Minami M, Nagatsu T (1989 a) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into N-methyl-isoquinolinium ion by monoamine oxidase. J Neurochem 52: 653–655
Naoi M, Matsuura S, Takahashi T, Nagatsu T (1989 b) An N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. Biochem Biophy Res Commun 161: 1213–1219
Naoi M, Takahashi T, Parvez H, Kabeya R, Taguchi E, Yamaguchi K, Hirata Y, Minami M, Nagatsu T (1989 c) N-Methylisoquinolinium ion as an inhibitor of tyrosine hydroxylase, aromatic L-amino acid decarboxylase and monoamine oxidase. Neurochem Int 15: 315–320
Naoi M, Niwa T, Yoshida M, Nagatsu T (1991) Tetrahydroisoquinoline and its derivatives: the occcurrence and the metabolism in the brain, and the effects on catecholamine metabolism. In: Nagatsu T, Narabayashi H, Yoshida M (eds) Parkinson's disease. From clinical aspects to molecular basis. Springer, Wien New York, pp 73–84
Naoi M, Dostert P, Yoshida M, Nagatsu T (1993) N-Methylated tetrahydro-isoquinolines as dopaminergic neurotoxins. Adv Neurol 60: 212–217
Naoi M, Maruyama W, Dostert P (1994 a) Binding of 1,2(N)-dimethyl-6,7-dihydroxy-isoquinolinium ion to melanin: effects of ferrous and ferric ion on the binding. Neurosci Lett 171: 9–12
Naoi M, Maruyama W, Niwa T, Nagatsu T (1994 b) Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin. J Neural Transm [Suppl] 41: 197–205
Naoi M, Maruyama W, Dostert P, Nakahara D, Takahashi T, Nagatsu T (1994 c) Metabolic bioactivation of endogenous isoquinolines as dopaminergic neurotoxins to elicit Parkinson's disease. In: Hanin I, Yoshida M, Fisher A (eds) Alzheimer's and Parkinson's diseases: recent development. Plenum Press, New York London (in press)
Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T (1987) Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroisoquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun 144: 1084–1089
Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Yoshida M, Kawachi M, Naoi M, Nagatsu T (1990) Endogenous synthesis of N-methyl-1,2,3,4-tetrahydro isoquinoline, a precursor of N-methylisoquinolinium ion, in brains of primates with parkinsonism after system administration of 1,2,3,4-tetrahydroisoquinoline. J Chromatogr 533: 145–151
Niwa T, Maruyama W, Nakahara D, Takeda N, Yoshizumi H, Tatematsu A, Takahashi A, Dostert P, Naoi M, Nagatsu T (1992) Presence of endogenous synthesis of N-methyl-salsolinol, an analog of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine, in rat brain during in vivo microdialysis with salsolinol as demonstrated by gas chromatog-raphy-mass spectrometry. J Chromatogr 578: 109–115
Ohta S, Kohno M, Makino Y, Tachikawa O, Hirobe M (1987) Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed Res 8: 453–456
Origitano T, Hannigan J, Collins MA (1981) Rat brain salsolinol and blood-brain barrier. Brain Res 224: 446–451
Perez-Polo JR, Werrbach-Perez K, Tiffany-Castiglioni (1979) A human clonal cell line model of differentiating neurons. Dev Biol 71: 341–355
Sjoequist B, Eriksson A, Winblad B (1982) Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog Clin Biol Res 90: 57–67
Strolin Benedetti M, Dostert P, Carminati P (1989) Influence of food intake on the enantiometric composition of urinary salsolinol in man. J Neural Transm 78: 43–53
Teitel S, O'Brein J, Brossi A (1972) Alkaloids in mammalian tissues. 2. Synthesis of (+)- and ( −)-1-substituted-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. J Med Chem 15: 845–846
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, T., Deng, Y., Maruyama, W. et al. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J. Neural Transmission 98, 107–118 (1994). https://doi.org/10.1007/BF01277014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01277014